T. Tsuchida

发表

Poly IC triggers a cathepsin D- and IPS-1-dependent pathway to enhance cytokine production and mediate dendritic cell necroptosis.

S. Akira, T. Kawai, H. Kumar, 2013, Immunity.

The inhibitory effect of cisplatin in combination with irradiation on lung tumor cell growth is due to induction of tumor cell apoptosis.

K. Higashino, T. Tsuchida, T. Kodama, 2000, International journal of oncology.

Analysis of immunosuppressive mechanisms by TGF-β on the generation of human LAK cells

K. Higashino, T. Tsuchida, M. Nishiura, 1994 .

Involvement of the NLRP3 Inflammasome in Innate and Humoral Adaptive Immune Responses to Fungal β-Glucan1

S. Akira, P. Koenig, T. Kawai, 2009, The Journal of Immunology.

The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA.

S. Akira, T. Kawai, T. Saitoh, 2010, Immunity.

Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.

H. Fujiwara, J. Shimizu, T. Hamaoka, 1986, Journal of immunology.

Suppressive Effect of Ultraviolet‐B‐Irradiation of Epidermal Cells on the Induction of Contact Sensitivity

H. Fujiwara, T. Hamaoka, T. Tsuchida, 1986, Microbiology and immunology.

The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice

K. Higashino, K. Kaneda, T. Tsuchida, 1997, Cancer Immunology, Immunotherapy.

Epidermal Langerhans cells can function as stimulatory cells but not as accessory cells in CTL induction.

H. Pehamberger, M. Iijima, G. Shearer, 1984, Journal of immunology.

Immunologic characterization of tumor-associated transplantation antigens on MM102 mammary tumor eliciting preferentially helper T cell activity.

H. Fujiwara, T. Hamaoka, T. Tsuchida, 1978, Journal of immunology.

Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1.

K. Okuno, H. Fujiwara, T. Hamaoka, 1985, Japanese journal of cancer research : Gann.

Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.

H. Fujiwara, G. Shearer, T. Hamaoka, 1984, Journal of immunology.

Tolerance induction in tumor-specific effector T cells by presensitization with tumor antigens via the intragastric route.

K. Okuno, H. Fujiwara, T. Hamaoka, 1984, Gan.

Inhibition of IRF3-dependent antiviral responses by cellular and viral proteins

S. Akira, T. Kawai, T. Tsuchida, 2009, Cell Research.

High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease.

T. Hada, K. Higashino, T. Tsuchida, 1999, Rheumatology.

MODULATION OF T CELL DIFFERENTIATION, ANTIGEN EXPRESSION, AND RADIOSENSITIVITY OF SUPPRESSOR CELLS DURING LATE PHASES OF GRAFT‐VERSUS‐HOST REACTIVITY

U. Hurtenbach, G. Shearer, T. Tsuchida, 1984, Transplantation.

Therapeutic Strategy for Advanced Hepatocellular Carcinoma Using Systemic Interleukin-2 Infusion and Local Low-Dose Irradiation

T. Hada, K. Higashino, H. Iijima, 1993 .

Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.

H. Fujiwara, T. Tsuchida, Y. Yamane, 1986, Japanese journal of cancer research : Gann.

The role of I-region associated antigen (Ia)-bearing accessory cells in the generation of cytotoxic T cells in a subpopulation of thymocytes.

K. Okuno, K. Takatsu, T. Hamaoka, 1986, Japanese journal of cancer research : Gann.

Functional characterization of the killer-helper factor responsible for the induction of cytotoxic T lymphocytes from thymocytes, and evidence for the nature of this factor as distinct from T cell-replacing factor (TRF) in regard to B cell triggering.

K. Okuno, K. Takatsu, T. Hamaoka, 1981, Journal of Immunology.

Antibody avidity maturation favors SARS-CoV-2 convalescents over vaccinated individuals granting breadth in neutralizability and tolerance against variants

E. Adachi, H. Kunishima, H. Kakeya, 2022, medRxiv.

Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.

H. Fujiwara, T. Hamaoka, T. Tsuchida, 1985, Journal of immunology.